Market Cap:
$ SEC Filings
| Filing | Filed On |
|---|---|
| KINNATE BIOPHARMA INC. | 14 Feb 2024 |
| SC 13G/A | 14 Feb 2024 |
| AMENDMENT NO. 1 | 14 Feb 2024 |
| 8-K | 16 Jan 2024 |
| FORM 4 SUBMISSION | 05 Dec 2023 |
| FORM 4 SUBMISSION | 05 Dec 2023 |
| FORM 4 SUBMISSION | 05 Dec 2023 |
| SC 13G | 27 Nov 2023 |
| 8-K | 22 Nov 2023 |
| AMENDMENT NO. 4 | 17 Nov 2023 |
| AMENDMENT NO. 5 | 17 Nov 2023 |
| 8-K | 15 Nov 2023 |
| AMENDMENT NO. 3 | 14 Nov 2023 |
| AMENDMENT NO. 4 | 14 Nov 2023 |
| 10-Q | 09 Nov 2023 |
| 8-K | 09 Nov 2023 |
| 8-K | 18 Sep 2023 |
| FORM 4 SUBMISSION | 06 Sep 2023 |
| FORM 4 SUBMISSION | 06 Sep 2023 |
| FORM 4 SUBMISSION | 06 Sep 2023 |
